13:38 03/12/2016 Despite Recent Market Upturn, This Stock Struggled This Week: Arena ...
Despite Recent Market Upturn, This Stock Struggled This Week: Arena ...
CSZ News - 20 hours ago
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock has moved in a downward direction over the past week, yielding losses for investors after the elections concluded.

12:37 03/12/2016 Brokerages Set Arena Pharmaceuticals Inc. (ARNA) PT at $3.75
Brokerages Set Arena Pharmaceuticals Inc. (ARNA) PT at $3.75
The Cerbat Gem - 21 hours ago
Arena Pharmaceuticals logo Arena Pharmaceuticals Inc. (NASDAQ:ARNA) has been assigned an average rating of “Hold” from the eight analysts that are covering the stock.
Arena Pharmaceuticals Inc. (ARNA) Moves Higher on Volume Spike for December 02 - Equities.com

3:22 03/12/2016 The Arena Pharmaceuticals Inc. (ARNA) Receives Consensus Rating of “Hold” from ...
The Arena Pharmaceuticals Inc. (ARNA) Receives Consensus Rating of “Hold” from ...
DailyQuint - Dec 3, 2016
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) has earned a consensus rating of “Hold” from the eight analysts that are covering the company.

12:05 02/12/2016 Scorching Hot Biotech Stocks Tape: Navidea Biopharmaceuticals, Inc (NAVB ...
Scorching Hot Biotech Stocks Tape: Navidea Biopharmaceuticals, Inc (NAVB ...
The Independent Republic - Dec 2, 2016
Navidea Biopharmaceuticals, Inc (NAVB) ended last trading session with a change of -8.47 percent. It trades at an average volume of 2.33M shares versus 1.89M shares recorded at the end of last trading session.

12:00 01/12/2016 Biotech Stocks Worth Chasing: Arena Pharmaceuticals, Inc. (ARNA), Arrowhead ...
Biotech Stocks Worth Chasing: Arena Pharmaceuticals, Inc. (ARNA), Arrowhead ...
The Independent Republic - Dec 1, 2016
Arena Pharmaceuticals, Inc. (ARNA) ended last trading session with a change of -3.97 percent. It trades at an average volume of 1.71M shares versus 1.44M shares recorded at the end of last trading session.
Arena Pharmaceuticals Inc. (ARNA) Receives Consensus Rating of "Hold" from ... - BBNS
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Insider Trading Update - The Newburgh Press

14:16 29/11/2016 Intraday Active Biotech Stocks News: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
Intraday Active Biotech Stocks News: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
The Voice Registrar - Nov 29, 2016
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) declined to $1.52 per share in the last trading day compared to a prior close of $1.61.

15:56 25/11/2016 Two Stocks in Concentration: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Exact ...
Two Stocks in Concentration: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Exact ...
FactsReporter - Nov 25, 2016
The company announced its last quarter financial performance results on 11/07/2016. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) belongs to Medical sector that surged 5.3% in value when last trading session closed at $1.59.
Upcoming Earnings Report: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - The Voice Registrar
Shorts On Watch: Could Arena Pharmaceuticals Incorporated (NASDAQ:ARNA) Change ... - Post News

14:50 09/11/2016 Hot Biotech Stocks To Watch Right Now: Arena Pharmaceuticals, Inc. (ARNA ...
Hot Biotech Stocks To Watch Right Now: Arena Pharmaceuticals, Inc. (ARNA ...
The Independent Republic - Nov 9, 2016
The company has a market cap of $388.54M and currently has 252.3M shares outstanding. The share price is currently -0.81 percent versus its SMA20, -5.67 percent versus its SMA50, and -8.2 percent versus its SMA200.

13:30 09/11/2016 Arena Pharmaceuticals Announces Poster at the American Heart Association (AHA ...
Arena Pharmaceuticals Announces Poster at the American Heart Association (AHA ...
PR Newswire (press release) - Nov 9, 2016
SAN DIEGO, Nov. 9, 2016 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that Professor Lucie Clapp will present a poster at the American Heart Association (AHA) Scientific Sessions 2016 on Monday, November 14 at ...

0:22 08/11/2016 3 Things You Really Need to Know About Arena Pharmaceuticals, Inc. Q3 Results
3 Things You Really Need to Know About Arena Pharmaceuticals, Inc. Q3 Results
Motley Fool - Nov 8, 2016
Like many biotechs, Arena Pharmaceuticals, Inc. (NASDAQ:ARIA) hasn't had a great year in 2016, so far. Shares of the biopharmaceutical company are down more than 20% year to date.
Needham Reiterates Hold on Arena Pharmaceuticals, Inc. (ARNA) Following 3Q:16 ... - Smarter Analyst
Arena Pharmaceuticals Inc. (ARNA) Announces Quarterly Earnings Results - Community Financial News